MSD’s PD-1 inhibitor Keytruda has been approved by the FDA as a treatment for locally advanced unresectable or metastatic biliary tract cancer (BTC) in combination with chemotherapy, the first ...

inoperable biliary tract cancer," Shroff said. "Our research also indicates that the three-drug regimen may increase the toxicity of the treatment." Shroff noted that the three-drug regimen might ...